News from naurex inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 31, 2010, 07:30 ET

Naurex's Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical...

Jun 17, 2010, 11:25 ET

Naurex Inc. Presents Positive Clinical Data on Novel Mechanism Antidepressant Candidate GLYX-13 at NCDEU 50th Anniversary Meeting

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented...

Feb 10, 2010, 07:00 ET

Naurex Inc. Reports Positive Top-Line Phase I Results for Its Novel Mechanism NMDA Receptor Modulator GLYX-13 in Treatment-Resistant Depression

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site...

Dec 16, 2009, 07:45 ET
Dec 16, 2009, 07:45 ET

Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression

Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA...